Tel Aviv - Delayed Quote ILA
Lineage Cell Therapeutics, Inc. (LCTX.TA)
158.60
+8.50
+(5.66%)
At close: 5:24:34 PM GMT+3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 1.72M | 1.72M | 11.28M | 23.57M |
| Low Estimate | -- | -- | 3.34M | -- |
| High Estimate | 3.56M | 3.65M | 30M | 45M |
| Year Ago Sales | 1.44M | 1.41M | 9.5M | 11.28M |
| Sales Growth (year/est) | 19.11% | 22.46% | 18.72% | 109.04% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LCTX.TA | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Maintains | B. Riley Securities: Buy to Buy | 3/14/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/11/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/31/2025 |
Related Tickers
ENLV.TA Enlivex Therapeutics Ltd.
330.60
-0.57%
BLRX.TA BioLineRx Ltd.
1.7000
0.00%
CGEN.TA Compugen Ltd.
536.60
+3.39%
NERV Minerva Neurosciences, Inc.
1.7450
+2.03%
PPBT Purple Biotech Ltd
2.7750
-1.25%
CGEN Compugen Ltd.
1.4350
-1.71%
BLRX BioLineRx Ltd.
3.0111
+3.83%
CLDX Celldex Therapeutics, Inc.
19.61
+1.13%
DYN Dyne Therapeutics, Inc.
11.05
+11.50%
MESO Mesoblast Limited
11.45
+5.39%